Medication Tapering/Withdrawal

In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.

After long-term use, most people are going to have serious symptoms when stopping SSRIs. Many people are going to have transient, mild to moderate difficulty and some are going to end up falling down the akathisia rabbit hole. That is a long, difficult drop.

Nobody told me what it would be like when I first stopped taking antidepressants. The worst is definitely over, but I’m still experiencing some lingering side effects. When the hyper-arousal to sights and sounds kicks in and my head starts buzzing, I’ve learned some ways to cope.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

My study, in which I slowly withdrew people from prescribed antipsychotics and antidepressants, found that it is possible to decrease both spending on psychiatric drugs and patients' chronic exposure to them. In general, the drug-reduction process was well-tolerated and well-accepted among those treated.

A full picture of the seven webinars that comprise our upcoming psychiatric withdrawal course, with presenters including Sandra Steingard, Peter Breggin, Kelly Brogan, Carina Hakansson, Will Hall and a panel of survivors. The course begins on October 24th and slots are filling fast!

My doctor insisted that my symptoms could not be associated with withdrawal – they had to be symptoms of an underlying condition. I have since learned from legitimate sources that protracted withdrawal syndrome from benzodiazepines can intensify long before it abates, with some symptoms lasting for years.

Sometimes I get so sick of the lies of biological psychiatry that I must speak out. At these moments I find silence to be a kind of emotional death: a death of my spirit, a death of my critical faculties, a death of my courage. I speak out because I am alive and I wish to align with life.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

“What I’d really like to do is stop everything,” I say. The reality is that psychiatrists are not the experts when it comes to getting people off psychiatric drugs.

Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.

When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

In a major study, published yesterday in JAMA Pediatrics, the use of SSRI antidepressants during pregnancy was found to increase the risk of autism spectrum disorder (ASD) by 87-percent. Previous studies reveal that more than 13-percent of women currently use SSRI antidepressants during pregnancy.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

The hearing for Bill H4062: Informed Consent for Benzodiazepines and Non-benzodiazepine Hypnotics took place on Monday – in the middle of an April snowstorm! The discussion clarified some important points in the legislation and gave survivors an opportunity to tell their stories. I was so proud to be there and witness the courage, camaraderie, resilience, advocacy, and vulnerability of fellow survivors. This legislation is our chance to be heard. As one survivor said, through tears, to the committee, “Do not let my suffering be in vain. I beg you to pass this bill.”

Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.

It is hard to believe that a year has gone past since I posted Playing the Odds: Antidepressant Withdrawal and the Problem of Informed Consent. The feedback I received underscored the more controversial aspects of SSRI toxicity.  Common themes concerned the abrupt onset of new symptoms 3 to 12 months after stopping the drug, reinstatement of the drug failing to help withdrawal related symptoms, the possibility that withdrawal-related symptoms can persist indefinitely and concerns about using benzodiazepines to help with tardive akathisia.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

Researchers from the City College of New York and Columbia University published a study this month testing the hypothesis that people diagnosed with schizophrenia treated long-term with antipsychotic drugs have worse outcomes than patients with no exposure to these drugs. They concluded that there is not a sufficient evidence base for the standard practice of long-term use of antipsychotic medications.

Rock climber, author, and MIA Blogger Matt Samet discusses his experience becoming addicted to, and subsequently coming off of, benzodiazepines.

A new study by Peter Groot and Jim van Os has found that tapering strips help people successfully discontinue antidepressant medications.

Healing mental health issues through correct supplements as well as nutrition is, I believe, the final factor for me in my journey. This is possibly what was missing in my first attempt at coming off, and why my brain and body couldn’t handle the extreme anxiety I felt in December 2013. I am ensuring that as I prepare to taper off the Lexapro in 2015, my brain and body are being supported in every way possible.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.